IQVIA to Announce Second-Quarter 2024 Results on July 22, 2024
08 Juli 2024 - 10:15PM
Business Wire
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its
second-quarter 2024 financial results before the market opens on
Monday, July 22, 2024. The IQVIA management team will also host a
conference call and webcast at 9:00 a.m. Eastern Time on that same
day. The earnings release and accompanying financial information
will be posted on the IQVIA Investor Relations website at
http://ir.iqvia.com.
To listen to the event and view the presentation slides via
webcast, join from the IQVIA Investor Relations website at
http://ir.iqvia.com. To participate in the conference call,
interested parties must register in advance by clicking on this
link. Following registration, participants will receive a
confirmation email containing details on how to join the conference
call, including the dial-in and a unique passcode and registrant
ID. At the time of the live event, registered participants can
connect to the call using the information provided in the
confirmation email and will be placed directly into the call.
A replay of the webcast will be available approximately two
hours after the conclusion of the live event. To access the webcast
recording, visit http://ir.iqvia.com.
About IQVIA IQVIA (NYSE:IQV) is a leading global provider
of advanced analytics, technology solutions, and clinical research
services to the life sciences industry. IQVIA creates intelligent
connections across all aspects of healthcare through its analytics,
transformative technology, big data resources, extensive domain
expertise and network of partners. IQVIA Connected Intelligence™
delivers actionable insights and powerful solutions with speed and
agility — enabling customers to accelerate the clinical development
and commercialization of innovative medical treatments that improve
healthcare outcomes for patients. With approximately 87,000
employees, IQVIA conducts operations in more than 100
countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
IQVIAFIN
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240708114466/en/
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)
+1.973.541.3558
Trent Brown, IQVIA Media Relations (trent.brown@iqvia.com)
+1.919.780.3221
IQVIA (NYSE:IQV)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
Von Nov 2023 bis Nov 2024